IMI2 Call documents
This page contains all documents relating to Calls for proposals and projects launched under the IMI2 programme. It includes Call texts, documents for applicants, Grant Agreements, project reporting documents, and reports.
IMI1 documents can be found on the IMI1 Call documents page.
Note that as of IMI2 – Call 10, proposals must be submitted via the electronic submission system of the Horizon 2020 Participant Portal.
- IMI2 - Call 16 | Call text
- IMI2 - Call 15 | Call text
- IMI2 - Call 14 | Call text
- IMI2 - Call 13 | Call text
- IMI2 - Call 12 | Call text
- IMI2 - Call 11 | Call text
- IMI2 - Call 10 | Call text
- IMI2 - Call 9 | Call text
- IMI2 - Call 8 | Call text
- IMI2 - Call 7 | Call text
- IMI2 - Call 6 | Call text
- IMI2 - Call 5 | Call text
- IMI2 - Call 4 | Call text
- IMI2 - Call 3 | Call text
- IMI2 - Call 2 | Call text
- IMI2 - Call 1 | Call text
- IMI2 Summary of most relevant provisions for participating in IMI2 actions
- IMI Manual for evaluation, submission and grant award
- version 1.6 (October 2017) - to be used from IMI2 - Call 13 onwards
- version 1.5 (5 July 2017) - to be used from IMI2 - Call 11 onwards
- Version 1.4 (October 2016) - to be used from IMI2 - Call 10 onwards
- Version 1.3 (April 2016) - to be used for IMI2 - Call 9
- Version 1.2.1 (June 2017) - to be used for proposals submitted under the fourth and fifth cut-off dates of IMI2 - Call 8, the open Call on Ebola and related diseases.
- Version 1.2 (December 2015) - to be used for IMI2 - Calls 1 to 7 inclusive, as well as for proposals submitted under the first three cut-off dates of IMI2 - Call 8, the open Call on Ebola and related diseases.
- Evaluation form for Research and Innovation Actions
- Evaluation form for Coordination and Support Actions
- Note on the IMI2 JU two-stage evaluation procedure
Application forms for submitting proposals
Research and Innovation Actions - Stage 1 - short proposal submission
- Proposal template
- Template for essential information for proposals including clinical trials / studies / investigations
Research and Innovation Actions - Stage 2 - full proposal submission
- Proposal template
Coordination and Support Actions - Stage 1 - short proposal submission
Coordination and Support Actions - Stage 2 - full proposal submission
The IMI2 JU Model Grant Agreement (MGA) is updated from time to time in line with the wider Horizon 2020 (H2020) MGA. The latest version of the IMI2 JU MGA can always be found via this link. Links to specific versions, along with the IMI2 Calls they apply to, are given below.
- Version 5 of November 2017 (applies to IMI2 - Call 13 on)
- Version 4 of May 2017 (applies to IMI2 - Call 11 and 12)
- Version 3 of November 2016 (applies to IMI2 - Call 10)
- Version 2 of February 2015 (applies to IMI2 - Calls 1-9 inclusive)
Generally speaking, changes only apply to new Grant Agreements. However, in certain cases (for example when it is advantageous for beneficiaries), changes can be applied retroactively by projects whose Grant Agreements are based on older versions of the Model Grant Agreement. This document explains this in more detail and summarises what is new in versions 3 and 4 compared to earlier versions, and which changes apply retroactively.
Need more information on grant agreement preparation and signature? Watch this Horizon 2020 webinar for coordinators of successful proposals.
All project partners must sign a consortium agreement that sets out participants’ rights and obligations and addresses issues like governance, liability and intellectual property rights. The agreement should be adapted to the needs of each project. A template prepared by EFPIA shows what a consortium agreement might look like. Consortia may also use alternative templates if they wish.
Project reporting documents
- Periodic report template, part B - pdf | Word
- Deliverable template pdf | Word
EFPIA and Associated Partners’ annual financial reporting:
IMI2 JU guidelines for reporting in kind and financial contributions by Members other than the Union and Associated Partners
Terms of reference for certification by independent external auditors of in-kind contributions Word document
As part of the Open Research Data Pilot (OPRD), all IMI2 projects are expected to provide a Data Management Plan (DMP) within the first six months. Read the Horizon 2020 guidance on DMPs, including a template plan.
To help prepare their data management plan, IMI2 projects should refer to the eTRIKS Standards Starter Pack.
Raising Awareness of Regulatory Requirements
Many IMI projects are developing tools and methods with a potential regulatory impact, such as tests and measures to evaluate medicines safety or efficacy, or alternative clinical trial designs. For this reason, we encourage all projects to seek regulatory engagement as early as possible. IMI has developed guidance for projects to raise awareness of the various opportunities to interact with regulators in the framework of research on regulatory sciences with a potential impact on public health. Through documents and webinars, we provide a high-level overview of the existing services offered by regulators. Note that these documents do not replace official procedures and requirements to validate or obtain formal advice from the relevant regulatory agencies.
- In December 2017, IMI held a webinar covering: EMA activities in support of EU-funded research projects for medicines innovation; the EMA’s Innovation Task Force; EMA’s qualification of novel methodologies; EMA support to SMEs; opportunities for engagement with the FDA to support drug development
Download the presentations | Watch the webinar online
- This guidance document (August 2015), developed jointly by EFPIA and IMI, summarises the services offered by regulators and is intended for use by researchers who wish to have a better understanding of these opportunities.
Links to relevant pages on the EMA and FDA websites
- European Medicines Agency (EMA) page on qualification of novel methodologies for medicine development
- Qualification of novel methodologies for drug development: guidance to applicants (EMA/CHMP/SAWP/72894/2008)
- European Medicines Agency process for engaging in external regulatory sciences and process improvement research activities for public and animal health
- U.S. Food & Drug Administration (FDA) page on Drug Development Tools Qualification Programs